Mycobacterium tuberculosis is a major
cause of death worldwide, and a formidable foe. Most healthy people can defend
themselves against tuberculosis, but they need all parts of their immune system
to work together. A study published in PLOS Pathogens reveals how a special
class of immune cells called "invariant natural killer T cells" make
their contribution to this concerted effort.
Specifically,
when invariant natural killer T (iNKT) cells encounter infected
macrophages--the human target cells of Mycobacterium
tuberculosis, or Mtb--the iNKT cells somehow prevented Mtb from growing and
multiplying inside the macrophages.
For
further details, refer to:
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources